Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Lyell Immunopharma, Inc. Common Stock (LYEL)

Pharmaceutical Preparations

https://www.lyell.com

Lyell Immunopharma Inc is a T cell reprogramming company dedicated towards the mastery of T cells to eradicate solid tumors. Its pipeline includes CARs (Chimeric antigen receptors), TILs (Tumor-infiltrating lymphocytes), and TCRs (T cell receptors).

201 HASKINS WAY
SOUTH SAN FRANCISCO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/17/2021

Market Cap

323,843,795

Shares Outstanding

251,870,000

Weighted SO

251,868,968

Total Employees

N/A

Upcoming Earnings

08/13/2024

Similar Tickers

CGEM --.--%

GLUE --.--%

THRX --.--%

RVMD --.--%

NKTX --.--%

GBIO --.--%

SANA --.--%

NUVB --.--%

IPSC --.--%

Beta

-0.5270

Last Div

0.0000

Range

1.18-3.256

Chg

0.0100

Avg Vol

976090

Mkt Cap

323843795

Exch

NASDAQ

Country

US

Phone

650 695 0677

DCF Diff

1.0560

DCF

0.2090

Div Yield

0.0000

P/S

5997.1073

EV Multiple

-1.2037

P/FV

0.5703

Div Yield %

0.0000

P/E

-1.5366

PEG

-0.0447

Payout

0.0000

Current Ratio

16.1865

Quick Ratio

16.1865

Cash Ratio

4.3209

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

76.3036

CCC

-76.3036

Gross Margin

-370.9630

Op Margin

-4227.8889

Pretax Margin

-3893.6852

Net Margin

-3893.6852

Eff Tax Rate

-0.0161

ROA

-0.3214

ROE

-0.3335

ROCE

-0.3663

NI/EBT

1.0000

EBT/EBIT

0.9210

EBIT/Rev

-4227.8889

Debt Ratio

0.0921

D/E

0.1063

LT Debt/Cap

0.0860

Total Debt/Cap

0.0961

Int Coverage

0.0000

CF/Debt

-2.6308

Equity Multi

1.1547

Rec Turnover

0.0000

Pay Turnover

4.7835

Inv Turnover

0.0000

FA Turnover

0.0004

Asset Turnover

0.0001

OCF/Share

-0.6203

FCF/Share

-0.6226

Cash/Share

1.9230

OCF/Sales

-2933.9074

FCF/OCF

1.0037

CF Coverage

-2.6308

ST Coverage

-22.9677

CapEx Coverage

-272.6867

Div&CapEx Cov

-272.6867

P/BV

0.5703

P/B

0.5703

P/S

5997.1073

P/E

-1.5366

P/FCF

-2.0366

P/OCF

-2.0392

P/CF

-2.0392

PEG

-0.0447

P/S

5997.1073

EV Multiple

-1.2037

P/FV

0.5703

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jun 23, 21:00 Lyell Immunopharma to Participate in the H.C. Wainwright “HCW@Home” Series

Revenue Product Segmentation